Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0000950135-08-003060
Filing Date
2008-04-29
Accepted
2008-04-29 14:35:34
Documents
6
Period of Report
2007-12-31

Document Format Files

Seq Description Document Type Size
1 INVERNESS MEDICAL INNOVATIONS, INC. FORM 10-K/A b68107kae10vkza.htm 10-K/A 1973682
2 EX-23.1 CONSENT OF BDO SEIDMAN, LLP b68107kaexv23w1.htm EX-23.1 2050
3 EX-31.1 SECTION 302 CERTIFICATION OF CEO b68107kaexv31w1.htm EX-31.1 5826
4 EX-31.2 SECTION 302 CERTIFICATION OF CFO b68107kaexv31w2.htm EX-31.2 5799
5 EX-32.1 SECTION 906 CERTIFICATION OF CEO & CFO b68107kaexv32w1.htm EX-32.1 4522
6 GRAPHIC b68107kab6810701.gif GRAPHIC 9727
  Complete submission text file 0000950135-08-003060.txt   2006881
Mailing Address 51 SAWYER ROAD SUITE 200 WALTHAM MA 02453
Business Address 51 SAWYER ROAD SUITE 200 WALTHAM MA 02453 7816473900
INVERNESS MEDICAL INNOVATIONS INC (Filer) CIK: 0001145460 (see all company filings)

EIN.: 043565120 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 001-16789 | Film No.: 08784755
SIC: 2835 In Vitro & In Vivo Diagnostic Substances